News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Protherics PLC Announces Final Results
June 3, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
London, UK, Brentwood, TN, 3 June 2008 - Protherics PLC, ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, today announces its preliminary results for the 12 months ended 31 March 2008.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Layoff Tracker
Mythic Cuts Staff While Sharpening Focus on Lead Candidate
October 6, 2025
·
215 min read
·
BioSpace Editorial Staff
Artificial intelligence
AstraZeneca Makes Another AI Deal With $555M Algen Alliance
October 6, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Chiesi, Arbor Weave $2.1B Rare Disease Pact
October 6, 2025
·
1 min read
·
Tristan Manalac
Mergers & acquisitions
How Akero’s MASH Success Drove Roche’s $3.5B Takeout of 89bio
October 2, 2025
·
3 min read
·
Annalee Armstrong
